Meropenem
From Biocrawler, the free encyclopedia.
Meropenem is an ultra-broad spectrum injectable antibiotic for a wide variety of serious infections, including meningitis and pneumonia.
Meropenem was developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca with the brand names Merrem and Meronem.
Unlike Immipenem, it is stable to renal dehydrogenase and can therefore be given without cilastatin. In penetrates into the CFS.
 | This medical treatment article is a stub. You can help Biocrawler by expanding it (http://www.biocrawler.com/w/index.php?title=Meropenem&action=edit). |
